Find Research Outputs

Search results

• Review article

  A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

  Kiaie, N., Gorabi, A. M., Penson, P. E., Watts, G., Johnston, T. P., Banach, M. & Sahebkar, A., Jan 2020, In : Drug Discovery Today. 25, 1, p. 58-72 15 p.

  Research output: Contribution to journal › Review article

  • Liposomes
  • Atherosclerosis
  • Cardiovascular Diseases
  • Angina Pectoris
  • Contrast Media
  3 Citations (Scopus)

• Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

  Cicero, A. F. G., Pirro, M., Watts, G. F., Mikhailidis, D. P., Banach, M. & Sahebkar, A., 1 Jan 2018, In : Drugs. 78, 1, p. 99-109 11 p.

  Research output: Contribution to journal › Review article

  • Allopurinol
  • Dilatation
  • Meta-Analysis
  • Systematic Reviews
  • Placebos
  19 Citations (Scopus)

• Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

  Watts, G. F., Gidding, S. S., Mata, P., Pang, J., Sullivan, D. R., Yamashita, S., Raal, F. J., Santos, R. D. & Ray, K. K., 23 Jan 2020, In : Nature Reviews Cardiology.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Ezetimibe
  • Blood Component Removal
  • Self-Help Groups
  • Precision Medicine
  8 Citations (Scopus)

• Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities

  Vuorio, A., Watts, G. F., Schneider, W. J., Tsimikas, S. & Kovanen, P. T., 1 Jan 2020, In : Journal of Internal Medicine. 287, 1, p. 2-18 17 p.

  Research output: Contribution to journal › Review article

  Open Access

  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • LDL Lipoproteins
  • Therapeutics
  • Cholesterol
  14 Citations (Scopus)

• In search of the vulnerable patient or the vulnerable plaque: F-sodium fluoride positron emission tomography for cardiovascular risk stratification

  Bellinge, J. W., Francis, R. J., Majeed, K., Watts, G. F. & Schultz, C. J., 10 Jul 2018, In : Journal of Nuclear Cardiology. 25, 5, p. 1774-1783

  Research output: Contribution to journal › Review article

  • Sodium Fluoride
  • Positron-Emission Tomography
  • Cardiovascular Diseases
  • Vascular Calcification
  • Calcium
  13 Citations (Scopus)

• Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

  Ellis, K. L. & Watts, G. F., 1 May 2018, In : Cardiology Clinics. 36, 2, p. 287-298 12 p.

  Research output: Contribution to journal › Review article

  • Lipoprotein(a)
  • Cardiovascular Diseases
  • Apoprotein(a)
  • Aortic Valve Stenosis
  • LDL Lipoproteins
  4 Citations (Scopus)

• Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal

  Boffa, M. B., Stranges, S., Klar, N., Moriarty, P. M., Watts, G. F. & Koschinsky, M. L., 1 Nov 2018, In : Journal of Clinical Lipidology. 12, 6, p. 1358-1366 9 p.

  Research output: Contribution to journal › Review article

  • Lipoprotein(a)
  • Secondary Prevention
  • Preexisting Condition Coverage
  • Coronary Disease
  • Population
  16 Citations (Scopus)

• MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy

  Mohajeri, M., Banach, M., Atkin, S. L., Butler, A. E., Ruscica, M., Watts, G. F. & Sahebkar, A., 1 Nov 2018, In : Trends in Pharmacological Sciences. 39, 11, p. 967-981 15 p.

  Research output: Contribution to journal › Review article

  • Modulators
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • MicroRNAs
  • Lipid Metabolism
  • Proprotein Convertases
  29 Citations (Scopus)

• Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience

  Ward, N. C., Pang, J., Ryan, J. D. M. & Watts, G. F., 24 Jan 2018, In : Clinical Cardiology. 41, 1, p. 159-165

  Research output: Contribution to journal › Review article

  Open Access

  • Dietary Supplements
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • LDL Cholesterol
  • Muscles
  • Cardiovascular Diseases
  10 Citations (Scopus)

• PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease

  Page, M. M. & Watts, G. F., 1 Feb 2018, In : Diabetes, Obesity and Metabolism. 20, 2, p. 270-282 13 p.

  Research output: Contribution to journal › Review article

  • Proprotein Convertase 9
  • Cardiovascular Diseases
  • Monoclonal Antibodies
  • ALN-PCS
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  17 Citations (Scopus)

• Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

  for the European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative, Feb 2020, In : Atherosclerosis. 294, p. 46-61 16 p.

  Research output: Contribution to journal › Review article

  Open Access

  • Lipoproteins
  • LDL Cholesterol
  • Atherosclerosis
  • Lipids
  • Cholesterol
  13 Citations (Scopus)

• Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

  Langlois, M. R., Nordestgaard, B. G., Langsted, A., Chapman, M. J., Aakre, K. M., Baum, H., Borén, J., Bruckert, E., Catapano, A., Cobbaert, C., Collinson, P., Descamps, O. S., Duff, C. J., Von Eckardstein, A., Hammerer-Lercher, A., Kamstrup, P. R., Kolovou, G., Kronenberg, F., Mora, S., Pulkki, K. & 9 others, Remaley, A. T., Rifai, N., Ros, E., Stankovic, S., Stavljenic-Rukavina, A., Sypniewska, G., Watts, G. F., Wiklund, O. & Laitinen, P., 1 Apr 2020, In : Clinical Chemistry and Laboratory Medicine. 58, 4, p. 496-517 22 p.

  Research output: Contribution to journal › Review article

  Open Access

  • Lipoproteins
  • LDL Cholesterol
  • lipoprotein cholesterol
  • Atherosclerosis
  • Lipids
  13 Citations (Scopus)

• Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part

  Brett, T., Qureshi, N., Gidding, S. & Watts, G. F., 1 Oct 2018, In : Atherosclerosis. 277, p. 399-406 8 p.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • General Practice
  • Primary Health Care
  • Information Technology
  • Electronic Health Records
  9 Citations (Scopus)

• The brave new world of genetic testing in the management of the dyslipidaemias

  Nawawi, H. M., Chua, Y. A. & Watts, G. F., 2020, In : Current Opinion in Cardiology. 35, 3, p. 226-233 8 p.

  Research output: Contribution to journal › Review article

  • Genetic Testing
  • Dyslipidemias
  • Familial Combined Hyperlipidemia
  • Hyperlipoproteinemia Type II
  • Familial HDL deficiency
  1 Citation (Scopus)

• The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia

  Pang, J., Chan, D. C. & Watts, G. F., Nov 2020, In : Current Atherosclerosis Reports. 22, 11, 64.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Therapeutics
  • Cardiovascular Diseases
  • LDL Cholesterol
  2 Citations (Scopus)

• The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats

  Hooper, A. J., Burnett, J. R., Bell, D. A. & Watts, G. F., 1 Jun 2018, In : Current Atherosclerosis Reports. 20, 6, 31.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Genetic Testing
  • High-Throughput Nucleotide Sequencing
  • Genomics
  • oxidized low density lipoprotein
  9 Citations (Scopus)

• The Role of Nutraceuticals in Statin Intolerant Patients

  International Lipid Expert Panel (ILEP), 3 Jul 2018, In : Journal of the American College of Cardiology. 72, 1, p. 96-118 23 p.

  Research output: Contribution to journal › Review article

  • Dietary Supplements
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • red yeast rice
  • Cynara scolymus
  • Cardiovascular Diseases
  81 Citations (Scopus)
• Letter

  Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk

  Vuorio, A., Watts, G. F. & Kovanen, P. T., 1 Jun 2020, In : Journal of Internal Medicine. 287, 6, p. 746-747 2 p.

  Research output: Contribution to journal › Letter

  Open Access
  16 Citations (Scopus)

• Familial Hypercholesterolemia in a Healthy Elderly Population

  Lacaze, P., Sebra, R., Riaz, M., Hooper, A. J., Tiller, J., Bakshi, A., Woods, R. L., Tonkin, A. M., Reid, C. M., Murray, A. M., Nicholls, S. J., Watts, G. F., Schadt, E. & McNeil, J. J., 1 Aug 2020, In : Circulation. Genomic and precision medicine. 13, 4, p. e002938

  Research output: Contribution to journal › Letter

• Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets

  Lan, N. S. R., Yeap, B. B., Bell, D. A., Watts, G. F. & Fegan, P. G., Sep 2020, In : Diabetes and Metabolism. 46, 4, p. 339-341 3 p.

  Research output: Contribution to journal › Letter
• Editorial

  Atherogenic Dyslipoproteinemia and Management of ASCVD: Will New Indices Untie the Gordian Knot?

  Watts, G. F. & Chan, D. C., 5 May 2020, In : Journal of the American College of Cardiology. 75, 17, p. 2136-2139 4 p.

  Research output: Contribution to journal › Editorial
  1 Citation (Scopus)

• Editorial introductions (in Current Opinion in Lipidology)

  Stroes, E. S. G. & Watts, G. F., Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-433 1 p.

  Research output: Contribution to journal › Editorial

• Familial hypercholesterolaemia registry in the MENA region

  Kolovou, G. & Watts, G. F., 2020, In : Current Vascular Pharmacology. 18, 1, 1 p.

  Research output: Contribution to journal › Editorial

  Open Access

  • Hyperlipoproteinemia Type II
  • LDL Receptors
  • Registries
  • Mutation
  • Genes

• Improving the global care of familial hypercholesterolaemia: Starting the ball rolling

  Ray, K. K. & Watts, G. F., 1 Oct 2018, In : Atherosclerosis. 277, p. 230-233 4 p.

  Research output: Contribution to journal › Editorial
  4 Citations (Scopus)

• PCSK9 monoclonal antibody on a knife-edge: An article of faith in FH?

  Ward, N. C. & Watts, G. F., 1 Jul 2018, In : Journal of Clinical Lipidology. 12, 4, p. 844-848 5 p.

  Research output: Contribution to journal › Editorial

• Squaring up the health economics of PCSK9 monoclonal antibodies ‘down under’

  Watts, G. F. & Norman, R., 15 Sep 2018, In : International Journal of Cardiology. 267, p. 193-194 2 p.

  Research output: Contribution to journal › Editorial
  3 Citations (Scopus)

• Very special case of primary prevention with statins

  Pang, J., Martin, A. & Watts, G., 20 Apr 2020, In : Journal of Paediatric and Child Health. 56, 4, p. 656

  Research output: Contribution to journal › Editorial
• Comment/debate

  Correction: Effect of Lipoprotein (a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?

  Chan, D., Pang, J., Hooper, A., Bell, D., Burnett, J. & Watts, G., 26 Apr 2020, In : Clinical Chemistry. 66, 5, p. 737-738

  Research output: Contribution to journal › Comment/debate

• Lipoprotein(a): lodestar for future clinical trials

  Watts, G. F. & Boffa, M. B., 13 Oct 2018, In : The Lancet. 392, 10155, p. 1281-1282 2 p.

  Research output: Contribution to journal › Comment/debate
  6 Citations (Scopus)
• Chapter

  Dyslipidemia

  Chan, D. T., Irish, A. B. & Watts, G. F., 1 Jan 2018, Handbook of Chronic Kidney Disease Management. 2nd ed. Kluwer Academic Publishers, p. 192-216 25 p.

  Research output: Chapter in Book/Conference paper › Chapter
• Article

  A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia

  Chan, D. C., Pang, J., Hooper, A. J., Bell, D. A., Bates, T. R., Burnett, J. R. & Watts, G. F., 1 Apr 2018, In : The Journal of clinical endocrinology and metabolism. 103, 4, p. 1704-1714

  Research output: Contribution to journal › Article

  Open Access

  File

  • Hyperlipoproteinemia Type II
  • Lipids
  • Xanthomatosis
  • Early Diagnosis
  • Mutation
  18 Citations (Scopus)

  706 Downloads (Pure)

• Acute Impact of Different Exercise Modalities on Arterial and Platelet Function

  Haynes, A., Linden, M. D., Robey, E., Watts, G. F., Barrett, P. H. R., Naylor, L. H. & Green, D. J., 1 Apr 2018, In : Medicine & Science in Sports & Exercise. 50, 4, p. 785–791

  Research output: Contribution to journal › Article

  • Blood Platelets
  • Exercise
  • Platelet Activation
  • Brachial Artery
  • Middle Aged
  2 Citations (Scopus)

• Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods

  Ibrahim, S., Reeskamp, L. F., Stroes, E. S. G. & Watts, G. F., 1 Dec 2020, In : Current Opinion in Lipidology. 31, 6, p. 347-355 9 p.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • Clinical Decision Support Systems
  • Child
  • Machine Learning

• An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia

  Pang, J., Abraham, A., Vargas-García, C., Bates, T. R., Chan, D. C., Hooper, A. J., Bell, D. A., Burnett, J. R., Schultz, C. J. & Watts, G. F., Apr 2020, In : Atherosclerosis. 298, p. 52-57 6 p.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Atherosclerotic Plaques
  • Coronary Vessels
  • Tomography
  • Coronary Artery Disease
  1 Citation (Scopus)

• Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey

  Banach, M., Mazidi, M., Mikhailidis, D. P., Toth, P. P., Jozwiak, J., Rysz, J. & Watts, G. F., 21 Oct 2018, In : European Heart Journal. 39, 40, p. 3635-3640 6 p.

  Research output: Contribution to journal › Article

  Open Access

  • Hyperlipoproteinemia Type II
  • Telomere
  • Confidence Intervals
  • Nutrition Surveys
  • Lipids

• Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease

  Golledge, J., Rowbotham, S., Velu, R., Quigley, F., Jenkins, J., Bourke, M., Bourke, B., Thanigaimani, S., Chan, D. C. & Watts, G. F., 17 Mar 2020, In : Journal of the American Heart Association. 9, 6, p. e015355

  Research output: Contribution to journal › Article

  Open Access

  • Lipoprotein(a)
  • Peripheral Arterial Disease
  • Arteries
  • Lower Extremity
  • Incidence

• Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study

  Mooranian, A., Raj Wagle, S., Kovacevic, B., Takechi, R., Mamo, J., Lam, V., Watts, G. F., Mikov, M., Golocorbin-Kon, S., Stojanovic, G., Al-Sallami, H. & Al-Salami, H., 1 Dec 2020, In : Scientific Reports. 10, 1, 106.

  Research output: Contribution to journal › Article

  Open Access

  • Probucol
  • Ursodeoxycholic Acid
  • Bile Acids and Salts
  • Capsules
  • Pharmacology
  4 Citations (Scopus)

• Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism

  Chan, D. C., Watts, G. F., Somaratne, R., Wasserman, S. M., Scott, R. & Barrett, P. H. R., Jul 2018, In : Arteriosclerosis, thrombosis, and vascular biology. 38, 7, p. 1644-1655 12 p.

  Research output: Contribution to journal › Article

  Open Access

  • Apolipoprotein B-48
  • Proprotein Convertase 9
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipoproteins
  • Triglycerides
  12 Citations (Scopus)

• Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics

  Watts, G. F., Chan, D. C., Somaratne, R., Wasserman, S. M., Scott, R., Marcovina, S. M. & Barrett, P. H. R., 14 Jul 2018, In : European Heart Journal. 39, 27, p. 2577-2585 9 p.

  Research output: Contribution to journal › Article

  • evolocumab
  • Proprotein Convertase 9
  • Lipoprotein(a)
  • Apoprotein(a)
  • Inhibition (Psychology)

• Coronary artery calcium scoring in cardiovascular risk assessment of people with family histories of early onset coronary artery disease

  Venkataraman, P., Stanton, T., Liew, D., Huynh, Q., Nicholls, S. J., Mitchell, G. K., Watts, G. F., Tonkin, A. M. & Marwick, T. H., 1 Aug 2020, In : Medical Journal of Australia. 213, 4, p. 170-177 8 p.

  Research output: Contribution to journal › Article

  • Risk Assessment
  • Coronary Artery Disease
  • Coronary Vessels
  • Calcium
  • Cardiovascular Diseases
  1 Citation (Scopus)

• Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia

  Page, M. M., Ellis, K. L., Pang, J., Chan, D. C., Hooper, A. J., Bell, D. A., Burnett, J. R. & Watts, G. F., 1 Nov 2020, In : Clinica Chimica Acta. 510, p. 211-215

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • Polymorphism
  • Coronary Artery Disease
  • Single Nucleotide Polymorphism

• Design, development and deployment of a web-based patient registry for rare genetic lipid disorders

  Napier, K. R., Hooper, A. J., Ng, D. M., Render, L., Bell, D. A., Pang, J., Watts, G. F., Bellgard, M. I. & Burnett, J. R., 7 Apr 2020, In : Pathology.

  Research output: Contribution to journal › Article

  • Inborn Genetic Diseases
  • Registries
  • Lipids
  • Hyperlipoproteinemia Type II
  • Rare Diseases
  1 Citation (Scopus)

• Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia

  Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 493-501 9 p.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Prescription Drug Overuse
  • Intention
  • Cholesterol
  • Psychological Models
  11 Citations (Scopus)

• Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis

  Ellis, K. L., Pang, J., Chieng, D., Bell, D. A., Burnett, J. R., Schultz, C. J., Hillis, G. S. & Watts, G. F., Mar 2018, In : Clinical Cardiology. 41, 3, p. 378-384

  Research output: Contribution to journal › Article

  • Coronary Care Units
  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • Coronary Artery Disease
  • Acute Coronary Syndrome
  13 Citations (Scopus)

• Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease

  Chieng, D., Pang, J., Ellis, K. L., Hillis, G. S., Watts, G. F. & Schultz, C. J., 3 Apr 2018, In : Journal of Clinical Lipidology. 12, 4, p. 1019-1026

  Research output: Contribution to journal › Article

  • Lipoprotein(a)
  • LDL Cholesterol
  • Coronary Artery Disease
  • Coronary Care Units
  • Hyperlipoproteinemia Type II
  12 Citations (Scopus)

• Familial hypercholesterolaemia and cascade testing in general practice: Lessons from COVID-19

  Garrahy, E., Heal, C., Hespe, C. M., Radford, J., Watts, G. F. & Brett, T., 1 Dec 2020, In : Australian journal of general practice. 49, 12, p. 859-860 2 p.

  Research output: Contribution to journal › Article

• Fenofibrate effects on carotid artery intima-media thickness in adults with type 2 diabetes mellitus: A FIELD substudy

  Harmer, J. A., Keech, A. C., Veillard, A. S., Skilton, M. R., Watts, G. F. & Celermajer, D. S., 1 Jul 2018, In : Diabetes Research and Clinical Practice. 141, p. 156-167 12 p.

  Research output: Contribution to journal › Article

  • Fenofibrate
  • Carotid Intima-Media Thickness
  • Carotid Arteries
  • Type 2 Diabetes Mellitus
  • Dyslipidemias
  2 Citations (Scopus)

• Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry

  Members of the FH Australasia Network Registry, Pang, J., Sullivan, D. R., Hare, D. L., Colquhoun, D. M., Bates, T. R., Ryan, J. D. M., Bishop, W., Burnett, J. R., Bell, D. A., Simons, L. A., Mirzaee, S., Kostner, K. M., Nestel, P. J., Wilson, A. M., O'Brien, R. C., Janus, E. D., Clifton, P. M., Ardill, J. J., Chan, D. C. & 2 others, van Bockxmeer, F. & Watts, G. F., 29 Aug 2020, In : Heart Lung and Circulation.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Registries
  • LDL Cholesterol
  • Coronary Artery Disease
  • Genetic Testing

• Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?

  Ademi, Z., Norman, R., Pang, J., Liew, D., Zoungas, S., Sijbrands, E., Ference, B., Wiegman, A. & Watts, G. F., Jul 2020, In : Atherosclerosis. 304, p. 1-8

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Quality-Adjusted Life Years
  • Health
  2 Citations (Scopus)

• Health literacy in familial hypercholesterolemia: A cross-national study

  Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Jun 2018, In : European Journal of Cardiovascular Prevention & Rehabilitation. 25, 9, p. 936-943

  Research output: Contribution to journal › Article

  Open Access

  File

  • Health Literacy
  • Hyperlipoproteinemia Type II
  • Income
  • China
  • Malaysia
  20 Citations (Scopus)

  241 Downloads (Pure)